Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4WOT

ROCK2 IN COMPLEX WITH 1426382-07-1

Summary for 4WOT
Entry DOI10.2210/pdb4wot/pdb
DescriptorRho-associated protein kinase 2, methyl 3-[({2'-(aminomethyl)-5'-[(3-fluoropyridin-4-yl)carbamoyl]biphenyl-3-yl}carbonyl)amino]-4-fluorobenzoate (3 entities in total)
Functional Keywordstransferase
Biological sourceHomo sapiens (Human)
Cellular locationCytoplasm: O75116
Total number of polymer chains4
Total formula weight183952.89
Authors
Augustin, M.,Krapp, S.,Boland, S.,Defert, O.,Bourin, A.,Alen, J.,Leysen, D. (deposition date: 2014-10-16, release date: 2015-05-06, Last modification date: 2024-05-08)
Primary citationBoland, S.,Bourin, A.,Alen, J.,Geraets, J.,Schroeders, P.,Castermans, K.,Kindt, N.,Boumans, N.,Panitti, L.,Fransen, S.,Vanormelingen, J.,Stassen, J.M.,Leysen, D.,Defert, O.
Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.
J. Med. Chem., 58:4309-4324, 2015
Cited by
PubMed Abstract: ROCK1 and ROCK2 play important roles in numerous cellular functions, including smooth muscle cell contraction, cell proliferation, adhesion, and migration. Consequently, ROCK inhibitors are of interest for treating multiple indications including cardiovascular diseases, inflammatory and autoimmune diseases, lung diseases, and eye diseases. However, systemic inhibition of ROCK is expected to result in significant side effects. Strategies allowing reduced systemic exposure are therefore of interest. In a continuing effort toward identification of ROCK inhibitors, we here report the design, synthesis, and evaluation of novel soft ROCK inhibitors displaying an ester function allowing their rapid inactivation in the systemic circulation. Those compounds display subnanomolar activity against ROCK and strong differences of functional activity between parent compounds and expected metabolites. The binding mode of a representative compound was determined experimentally in a single-crystal X-ray diffraction study. Enzymes responsible for inactivation of these compounds once they enter systemic circulation are also discussed.
PubMed: 25898023
DOI: 10.1021/acs.jmedchem.5b00308
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.93 Å)
Structure validation

248636

PDB entries from 2026-02-04

PDB statisticsPDBj update infoContact PDBjnumon